Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 16;27(22):7941. doi: 10.3390/molecules27227941

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

The effects of ellagic acid (EA) on levels of six immune mediators in TZM-bl cell supernatants, measured by Luminex technology at 48 h in cells treated with EA before (Pre-treatment) or after HIV-1 challenge (Post-treatment). The mediators are IL-2 (A), IL-4 (B), TNFα (C), IL-8 (D), CCL2 (E) and IL-6 (F). Bars show the mean concentration ± SD of two independent experiments. The four additional cytokines that were measured concurrently were below the level of detection and are therefore not shown.

The effects of ellagic acid (EA) on levels of six immune mediators in TZM-bl cell supernatants, measured by Luminex technology at 48 h in cells treated with EA before (Pre-treatment) or after HIV-1 challenge (Post-treatment). The mediators are IL-2 (A), IL-4 (B), TNFα (C), IL-8 (D), CCL2 (E) and IL-6 (F). Bars show the mean concentration ± SD of two independent experiments. The four additional cytokines that were measured concurrently were below the level of detection and are therefore not shown.